BRCA1 and BRCA2: penetrating the clinical arena.

doi:10.1016/S0140-6736(05)60738-6

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

BRCA1 and BRCA2: penetrating the clinical arena.

Lancet (London, England) - 24 Oct 1998

Foulkes W D

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA2 Protein
Share to Breast Neoplasms
Share to Breast Neoplasms, Male
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Iceland

Share to Neoplasm Proteins

Share to Penetrance

Share to Prognosis

Source

Open in PubMed

Identifiers

PMID: 9802263
DOI: 10.1016/S0140-6736(05)60738-6

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRCA1 and BRCA2: penetrating the clinical arena.PMID 9802263Read ↗

Cancer. BRCA2 enters the fray.Semantic proximity Read ↗

BRCA1 and BRCA2: to test or not to test.Semantic proximity Read ↗

BRCA1 and BRCA2.Semantic proximity Read ↗

BRCA1 and BRCA2 - update and implications on the genetics of breast cancer: a clinical perspective.Semantic proximity Read ↗

Biomedicine. D-Day for BRCA2.Semantic proximity Read ↗

BRCA-associated cancer risk: molecular biology and clinical practice.Semantic proximity Read ↗

Experts say more women should be tested for BRCA1 and BRCA2 genetic mutations.Semantic proximity Read ↗

BRCA1 and BRCA2 in breast cancer.Semantic proximity Read ↗

BRCA2: a 25-year journey from gene identification to targeted cancer treatment.Semantic proximity Read ↗

BRCA screening.Semantic proximity Read ↗

Clinical management of BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

BRCA in breast cancer: ESMO clinical recommendations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.